Skip to main content
. Author manuscript; available in PMC: 2014 Nov 22.
Published in final edited form as: Clin Cancer Res. 2012 Feb 10;18(7):2012–2023. doi: 10.1158/1078-0432.CCR-11-2483

Figure 2.

Figure 2

Figure 2

Kaplan-Meier analyses and log-rank estimates for OS and EFS of the validation cohort set 3 classified according to the (Y96) model (A and B), INRG (C and D), GPOH NB2004 (E and F).

COG (G and H), and JANB (I and J). HR, high-risk; IR, intermediate-risk; LR, low-risk.